Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3052)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2024 (publication date) through Oct 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Han F, Wang XH, Xu CZ. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(7): 3308-3320 [PMID: 39072161 DOI: 10.4251/wjgo.v16.i7.3308] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Han F, Wang XH, Xu CZ. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(7): 3308-3320 [PMID: 39072161 DOI: 10.4251/wjgo.v16.i7.3308] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i7/3308.htm |
| Number | Citing Articles |
| 1 |
Zejin Zhao, Yue Xiao, Chen-guang Su, Hui Zhao, Jian Li, Jinlong Liu. Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1661923
|